Latest news with #Virginia-based
Yahoo
a day ago
- Business
- Yahoo
Is Leidos Holdings Stock Outperforming the Dow?
Valued at a market cap of $19.1 billion, Leidos Holdings, Inc. (LDOS) is a technology company serving government and commercial clients. The Reston, Virginia-based company provides solutions across defense, intelligence, civil, and health sectors, specializing in areas such as mission systems, cybersecurity, AI-powered analytics, cloud modernization, air traffic management, energy infrastructure, and biomedical research. Companies worth $10 billion or more are typically classified as 'large-cap stocks,' and LDOS fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the information technology services industry. The company's long-standing relationships with key U.S. federal agencies, including the Department of Defense, Homeland Security, and the FAA, provide strong revenue visibility through multi-year government contracts. Its specialty lies in delivering complex, integrated solutions that combine advanced technologies like AI, machine learning, cloud modernization, and data analytics with domain-specific expertise. 'It Has No Utility': Warren Buffett Doesn't Care How High Gold Goes, He Isn't a Buyer OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. This tech company is currently trading 26.9% below its 52-week high of $202.90, reached on Nov. 12, 2024. LDOS has rallied 7% over the past three months, outpacing the Dow Jones Industrial Average's ($DOWI) 1.4% uptick during the same time frame. Moreover, on a YTD basis, shares of LDOS are up 3%, outperforming DOWI's marginal downtick. However, in the longer term, LDOS has gained 3.1% over the past 52 weeks, lagging behind DOWI's 8.6% rise over the same time frame. To confirm its recent bullish trend, LDOS has been trading above its 50-day moving average since early April, with slight fluctuations. However, it has remained below its 200-day moving average since mid-December, 2024, with some fluctuations. On May 6, Leidos Holdings' shares rose 4.6% following its better-than-expected Q1 earnings release. Due to increased demand across all customer segments, its revenue grew 6.8% year-over-year to $4.2 billion, exceeding Wall Street expectations by 4.2%. Moreover, solid margin expansion compared to the prior-year quarter led to a 29.7% growth in its adjusted EPS to $2.97. The bottom-line figure also surpassed the consensus estimates by a notable margin of 20.2%. The company's impressive performance was supported by higher volumes in managed health services programs, improved program execution, and effective cost management across operations. LDOS has lagged behind its rival, CACI International Inc (CACI), which gained 5.3% over the past 52 weeks and 12.5% on a YTD basis. Looking at LDOS' recent outperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of "Moderate Buy' from the 15 analysts covering it, and the mean price target of $173.80 suggests a 17.2% premium to its current price levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Geek Wire
2 days ago
- Politics
- Geek Wire
Seattle lawmakers approve GPS tracking tech for police pursuits
(GeekWire File Photo) The Seattle City Council voted 8-1 on Tuesday to authorize the Seattle Police Department's use of GPS tracking devices designed to reduce dangerous high-speed police chases. The approval of CB 120994 comes amid questions about the technology's effectiveness and concerns about expanding surveillance capabilities. The system, built by Virginia-based StarChase, uses compressed-air launchers mounted on police vehicles to fire battery-powered GPS tracking projectiles onto suspect vehicles during pursuits, theoretically enabling them to monitor the suspect's location remotely. The technology is being funded through a $250,000 state grant that will cover installation on 25 SPD vehicles and a two-year software subscription. Other police departments around Washington state and the U.S. have tested StarChase with varying levels of success. Last year the Oakland Police Department said it would stop using the technology. Privacy advocates, meanwhile, say the technology expands police power and could 'enable warrantless surveillance,' according to a statement from ACLU of Washington, as reported by The Urbanist. ACLU also said it was concerned about sharing of data and people's privacy. The bill describes the system's use as limited to vehicles where 'probable cause or reasonable suspicion of involvement in a crime has been established.' The new law comes as Washington state has significantly loosened restrictions on police pursuits. Lawmakers last year passed Initiative 2113, which allows officers to chase suspects based on 'reasonable suspicion' of any crime, dramatically expanding from previous laws that limited pursuits to serious violent offenses. 'This could be an incredible move forward for our city in terms of public safety, because of the importance of the issue of pursuit,' councilmember Bob Kettle, who sponsored the legislation, said during Tuesday's meeting. Police pursuits have become an increasingly urgent public safety concern nationwide. A San Francisco Chronicle investigation last year found that police chases kill nearly two people a day in the U.S., while 551 bystanders were killed in chases from 2017 to 2022. 'This is about bringing a comprehensive approach to what we're doing,' Kettle said, noting the system would integrate with SPD's new Real Time Crime Center. SPD uses various other technology including automated license plate readers and CCTV cameras. A push from Mayor Bruce Harrell to implement controversial gunshot detection tech didn't move forward last year.
Yahoo
3 days ago
- Business
- Yahoo
Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen
Privia Health Group, Inc. (NASDAQ:PRVA) is among the best NASDAQ stocks under $50 to buy. Analysts at TD Cowen have named Privia Health Group, Inc. (NASDAQ:PRVA) its 'Best Smidcap Idea' while maintaining a Buy rating and a $30.00 price target. This potential surge of about 31% from the current price is driven by the company's robust financial footing, which includes zero debt and more than $400 million in cash. Over the years, Privia Health Group, Inc. (NASDAQ:PRVA) has delivered improved results, with PRVA's 17.08% year-to-date return surpassing the market's 2.58% return. The leading investment bank believes that the company possesses the potential to deliver more than 20% EBITDA growth not only in 2025 but also in 2026. This is anything but ordinary, given the current market pessimism. A physician leveraging innovative technology to enable their patient care decisions. What makes Privia Health Group, Inc. (NASDAQ:PRVA) stand out the most is its capital-light business model that yields positive free cash flow in addition to maintaining impressive EBITDA growth. The analysts believe that this is the perfect blend for the powerhouse's scalable and predictable business operation. Privia Health Group, Inc. (NASDAQ:PRVA) is a Virginia-based physician-enablement company that partners with physician practices, health plans, and health systems to provide technology and population health tools. Founded in 2007, the company also manages an accountable care organization for enhanced coordination and patient quality metrics. While we acknowledge the potential of PRVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen
Privia Health Group, Inc. (NASDAQ:PRVA) is among the best NASDAQ stocks under $50 to buy. Analysts at TD Cowen have named Privia Health Group, Inc. (NASDAQ:PRVA) its 'Best Smidcap Idea' while maintaining a Buy rating and a $30.00 price target. This potential surge of about 31% from the current price is driven by the company's robust financial footing, which includes zero debt and more than $400 million in cash. Over the years, Privia Health Group, Inc. (NASDAQ:PRVA) has delivered improved results, with PRVA's 17.08% year-to-date return surpassing the market's 2.58% return. The leading investment bank believes that the company possesses the potential to deliver more than 20% EBITDA growth not only in 2025 but also in 2026. This is anything but ordinary, given the current market pessimism. A physician leveraging innovative technology to enable their patient care decisions. What makes Privia Health Group, Inc. (NASDAQ:PRVA) stand out the most is its capital-light business model that yields positive free cash flow in addition to maintaining impressive EBITDA growth. The analysts believe that this is the perfect blend for the powerhouse's scalable and predictable business operation. Privia Health Group, Inc. (NASDAQ:PRVA) is a Virginia-based physician-enablement company that partners with physician practices, health plans, and health systems to provide technology and population health tools. Founded in 2007, the company also manages an accountable care organization for enhanced coordination and patient quality metrics. While we acknowledge the potential of PRVA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Times
4 days ago
- Business
- Business Times
Michael Saylor shifts to using preferred shares to buy Bitcoin as criticism rises
[NEW YORK] Michael Saylor's Strategy bought US$1.05 billion in Bitcoin in the last seven days, the third consecutive week in which the cryptocurrency treasury company has used preferred shares exclusively instead of common stock to fund purchases. The company formerly known as MicroStrategy purchased 10,100 Bitcoin from Jun 9 to Jun 15 at an average price of US$104,080, according to a filing on Monday (Jun 16). The haul was the largest by Strategy in five weeks, raising its total holdings to roughly US$63.4 billion. The emphasis on preferred shares comes as Saylor's cryptocurrency accumulation strategy attracts more attention from critics who have raised concern over the large premium the company's common stock commands over the value of its token holdings. Legendary short-seller Jim Chanos called Saylor a 'salesman' and has recommended buying Bitcoin and shorting Strategy's common shares on a bet the premium will close. Saylor announced plans earlier this year to raise US$84 billion in capital to buy Bitcoin through a combination of at-the-market common share sales and debt offerings over the next few years. In 2020, Strategy began buying Bitcoin with cash on hand before shifting to stock sales. The Tysons Corner, Virginia-based firm, which started as an enterprise software maker, has issued three classes of preferred shares, and has also used convertible bonds to buy Bitcoin. Selling more common shares can dilute the holdings of existing shareholders, while preferred stock can also have the same impact if the securities are convertible to common. 'There's definitely the potential for dilution,' said Mark Palmer, an analyst at Benchmark Capital, who has a 'buy' rating on Strategy. 'But the trade-off is that it's only the convertible instruments that enable Strategy to sell volatility into the market. At the same time, there is an understanding that dilution or other instruments that are linked to common shares are part of the strategy.' The company funded the bulk of its purchases in the past week from the proceeds of the launch of its third class of preferred shares, which raised US$979.7 million. It raised an additional US$78.4 million from the sale of its so-called Strike and Strife preferred shares, according to the filing with the US Securities and Exchange Commission. Saylor clapped back at comments from Chanos and other critics last week, saying Strategy's ability to raise funds 'at a premium' through the sale of its preferred stock was 'effectively risk-free'. Strategy shares were little changed at around US$382 on Monday, and are up over 3,000 per cent since July 2020. The S&P 500 Index has climbed around 94 per cent during the same period, while Bitcoin has rallied about 1,060 per cent. BLOOMBERG
